The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins
Abstract
Through the study of transcriptional activation in response to interferon alpha (IFN-alpha) and interferon gamma (IFN-gamma), a previously unrecognized direct signal transduction pathway to the nucleus has been uncovered: IFN-receptor interaction at the cell surface leads to the activation of kinases of the Jak family that then phosphorylate substrate proteins called STATs (signal transducers and activators of transcription). The phosphorylated STAT proteins move to the nucleus, bind specific DNA elements, and direct transcription. Recognition of the molecules involved in the IFN-alpha and IFN-gamma pathway has led to discoveries that a number of STAT family members exist and that other polypeptide ligands also use the Jak-STAT molecules in signal transduction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Signal transducer and activator of transcription 3 (STAT3) belongs to the family of STAT transcription factors which mediate the cellular response to a variety of cytokines and growth factors including IL-6 (6-8”
From STAT3 Contributes to the Mitogenic Response of Hepatocytes during Liver Regeneration (2002) · cites this paper as [6]
In the citing paper
“Specifically, STAT1 and IRF5 have been shown to be involved in polarization and maintenance of an M1 phenotype while STAT6, IRF4, CREB-C/EBPβ, and PPARγ are involved in polarization and maintenance of an M2 phenotype [23–30].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [23]
Citations
Cites
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
Kessler, D. S., Veals, S. A., Fu, X. Y., & Levy, D. E. (1990) · Genes & Development · doi:10.1101/gad.4.10.1753 · Cited by 312
Cohen, B., Peretz, D., Vaiman, D., Benech, P., & Chebath, J. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02958.x · Cited by 180
Flagged first, then by citations
Research works printed but not linked: 84
- AGUET, M, MOLECULAR-CLONING AND EXPRESSION OF THE HUMAN INTERFERON-GAMMA RECEPTOR, CELL 55: 273 (1988). · DOI
- ALMENDRAL, J.M., COMPLEXITY OF THE EARLY GENETIC RESPONSE TO GROWTH-FACTORS IN MOUSE FIBROBLASTS, MOLECULAR AND CELLULAR BIOLOGY 8: 2140 (1988).
- 10.1016/0092-8674(93)90415-M · DOI
- BEADLING, C, ISOLATION OF INTERLEUKIN-2-INDUCED IMMEDIATE-EARLY GENES, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 2719 (1993).
- BLANAR, M.A., TRANSCRIPTIONAL ACTIVATION OF HLA-DR-ALPHA BY INTERFERON-GAMMA REQUIRES A TRANS-ACTING PROTEIN, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 85: 4672 (1988).
- 10.1126/science.7504325 · DOI
- COLAMONICI, O.R., MULTICHAIN STRUCTURE OF THE IFN-ALPHA RECEPTOR ON HEMATOPOIETIC-CELLS, JOURNAL OF IMMUNOLOGY 148: 2126 (1992). · DOI
- DALE, T.C., OVERLAPPING SITES FOR CONSTITUTIVE AND INDUCED DNA-BINDING FACTORS INVOLVED IN INTERFERON-STIMULATED TRANSCRIPTION, EMBO JOURNAL 8: 831 (1989). · DOI
- DALE, T.C., RAPID ACTIVATION BY INTERFERON-ALPHA OF A LATENT DNA-BINDING PROTEIN PRESENT IN THE CYTOPLASM OF UNTREATED CELLS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 86: 1203 (1989).
- 10.1126/science.1496402 · DOI
- DECKER, T, INTERACTIONS OF ALPHA-INTERFERON AND GAMMA-INTERFERON IN THE TRANSCRIPTIONAL REGULATION OF THE GENE ENCODING A GUANYLATE-BINDING PROTEIN, EMBO JOURNAL 8: 2009 (1989). · DOI
- DECKER, T, CYTOPLASMIC ACTIVATION OF GAF, AN IFN-GAMMA-REGULATED DNA-BINDING FACTOR, EMBO JOURNAL 10: 927 (1991). · DOI
- FIRMBACHKRAFT, I, TYK2, PROTOTYPE OF A NOVEL CLASS OF NONRECEPTOR TYROSINE KINASE GENES, ONCOGENE 5: 1329 (1990).
- 10.1126/science.1650499 · DOI
- 10.1093/nar/9.23.6505 · DOI
- FRIEDMAN, R.L., TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL REGULATION OF INTERFERON-INDUCED GENE-EXPRESSION IN HUMAN-CELLS, CELL 38: 745 (1984). · DOI
- 10.1016/0092-8674(92)90106-M · DOI
- FU, X.Y., ISGF3, THE TRANSCRIPTIONAL ACTIVATOR INDUCED BY INTERFERON-ALPHA, CONSISTS OF MULTIPLE INTERACTING POLYPEPTIDE-CHAINS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 87: 8555 (1990).
- FU, X.Y., THE PROTEINS OF ISGF-3, THE INTERFERON ALPHA-INDUCED TRANSCRIPTIONAL ACTIVATOR, DEFINE A GENE FAMILY INVOLVED IN SIGNAL TRANSDUCTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 89: 7840 (1992).
- GARRER, M.M., NUCLEIC ACIDS RES 9: 3047 (1981). · DOI
- 10.1126/science.1898992 · DOI
- GREENBERG, M.E., NERVE GROWTH-FACTOR AND EPIDERMAL GROWTH-FACTOR INDUCE RAPID TRANSIENT CHANGES IN PROTO-ONCOGENE TRANSCRIPTION IN PC12 CELLS, JOURNAL OF BIOLOGICAL CHEMISTRY 260: 14101 (1985). · DOI
- 10.1038/311433a0 · DOI
- HARADA, H, STRUCTURALLY SIMILAR BUT FUNCTIONALLY DISTINCT FACTORS, IRF-1 AND IRF-2, BIND TO THE SAME REGULATORY ELEMENTS OF IFN AND IFN-INDUCIBLE GENES, CELL 58: 729 (1989). · DOI
- HARPUR, A.G., ONCOGENE 7: 895 (1992).
- HEMMI, S, A NOVEL MEMBER OF THE INTERFERON RECEPTOR FAMILY COMPLEMENTS FUNCTIONALITY OF THE MURINE INTERFERON-GAMMA RECEPTOR IN HUMAN-CELLS, CELL 76: 803 (1994). · DOI
- IGARASHI, K, IN-VITRO ACTIVATION OF A TRANSCRIPTION FACTOR BY GAMMA-INTERFERON REQUIRES A MEMBRANE-ASSOCIATED TYROSINE KINASE AND IS MIMICKED BY VANADATE, MOLECULAR AND CELLULAR BIOLOGY 13: 3984 (1993).
- Improta, T., Proceedings of the National Academy of Sciences of the United States of America 91: 4776 (1994).
- JOHN, J, ISOLATION AND CHARACTERIZATION OF A NEW MUTANT HUMAN CELL-LINE UNRESPONSIVE TO ALPHA-INTERFERONS AND BETA-INTERFERONS, MOLECULAR AND CELLULAR BIOLOGY 11: 4189 (1991).
- KAHN, K.D., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 6806 (1993).
- KANNO, Y, THE GENOMIC STRUCTURE OF THE MURINE ICSBP GENE REVEALS THE PRESENCE OF THE GAMMA INTERFERON-RESPONSIVE ELEMENT, TO WHICH AN ISGF3-ALPHA SUBUNIT (OR SIMILAR) MOLECULE BINDS, MOLECULAR AND CELLULAR BIOLOGY 13: 3951 (1993).
- KESSLER, D.S., 2 INTERFERON-INDUCED NUCLEAR FACTORS BIND A SINGLE PROMOTER ELEMENT IN INTERFERON-STIMULATED GENES, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 85: 8521 (1988).
- 10.1126/science.1708916 · DOI
- 10.1126/science.7694370 · DOI
- 10.1126/science.8378773 · DOI
- LARNER, A.C., TRANSCRIPTIONAL INDUCTION BY INTERFERON - NEW PROTEIN(S) DETERMINE THE EXTENT AND LENGTH OF THE INDUCTION, JOURNAL OF BIOLOGICAL CHEMISTRY 261: 453 (1986). · DOI
- LARNER, A.C., TRANSCRIPTIONAL INDUCTION OF 2 GENES IN HUMAN-CELLS BY BETA-INTERFERON, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES 81: 6733 (1984).
- LEE, T.H., ISOLATION AND CHARACTERIZATION OF 8 TUMOR NECROSIS FACTOR-INDUCED GENE-SEQUENCES FROM HUMAN FIBROBLASTS, MOLECULAR AND CELLULAR BIOLOGY 10: 1982 (1990).
- LEVY, D, NEW BIOL 2: 923 (1990).
- LEVY, D.E., SYNERGISTIC INTERACTION BETWEEN INTERFERON-ALPHA AND INTERFERON-GAMMA THROUGH INDUCED SYNTHESIS OF ONE SUBUNIT OF THE TRANSCRIPTION FACTOR ISGF3, EMBO JOURNAL 9: 1105 (1990). · DOI
- LEVY, D.E., CYTOPLASMIC ACTIVATION OF ISGF3, THE POSITIVE REGULATOR OF INTERFERON-ALPHA-STIMULATED TRANSCRIPTION, RECONSTITUTED INVITRO, GENES & DEVELOPMENT 3: 1362 (1989). · DOI
- LEVY, D.E., INTERFERON-INDUCED NUCLEAR FACTORS THAT BIND A SHARED PROMOTER ELEMENT CORRELATE WITH POSITIVE AND NEGATIVE TRANSCRIPTIONAL CONTROL, GENES & DEVELOPMENT 2: 383 (1988). · DOI
- Levy, D. E., Interferon: Principles and Medical Applications: 161 (1992).
- LEW, D.J., ALPHA-INTERFERON AND GAMMA INTERFERON STIMULATE TRANSCRIPTION OF A SINGLE GENE THROUGH DIFFERENT SIGNAL TRANSDUCTION PATHWAYS, MOLECULAR AND CELLULAR BIOLOGY 9: 5404 (1989).
- LEW, D.J., OVERLAPPING ELEMENTS IN THE GUANYLATE-BINDING PROTEIN GENE PROMOTER MEDIATE TRANSCRIPTIONAL INDUCTION BY ALPHA AND GAMMA INTERFERONS, MOLECULAR AND CELLULAR BIOLOGY 11: 182 (1991).
- LUSTER, A.D., GAMMA-INTERFERON TRANSCRIPTIONALLY REGULATES AN EARLY-RESPONSE GENE CONTAINING HOMOLOGY TO PLATELET PROTEINS, NATURE 315: 672 (1985). · DOI
- MAO, C, MUTANT HUMAN-CELLS DEFECTIVE IN INDUCTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENES BY INTERFERON-GAMMA, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 2880 (1993).
- MCKENDRY, R, HIGH-FREQUENCY MUTAGENESIS OF HUMAN-CELLS AND CHARACTERIZATION OF A MUTANT UNRESPONSIVE TO BOTH ALPHA INTERFERON AND GAMMA INTERFERON, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 88: 11455 (1991).
- MIRKOVITCH, J, MAPPING OF RNA-POLYMERASE ON MAMMALIAN GENES IN CELLS AND NUCLEI, MOLECULAR BIOLOGY OF THE CELL 3: 1085 (1992). · DOI
- MIYAMOTO, M, REGULATED EXPRESSION OF A GENE ENCODING A NUCLEAR FACTOR, IRF-1, THAT SPECIFICALLY BINDS TO IFN-BETA-GENE REGULATORY ELEMENTS, CELL 54: 903 (1988). · DOI
- MULLER, M, COMPLEMENTATION OF A MUTANT-CELL LINE - CENTRAL ROLE OF THE 91-KDA POLYPEPTIDE OF ISGF3 IN THE INTERFERON-ALPHA AND INTERFERON-GAMMA SIGNAL-TRANSDUCTION PATHWAYS, EMBO JOURNAL 12: 4221 (1993). · DOI · Paper page
- MULLER, M, THE PROTEIN-TYROSINE KINASE JAK1 COMPLEMENTS DEFECTS IN INTERFERON-ALPHA/BETA AND INTERFERON-GAMMA SIGNAL-TRANSDUCTION, NATURE 366: 129 (1993). · DOI
- MURDOCH, G.H., EPIDERMAL GROWTH-FACTOR RAPIDLY STIMULATES PROLACTIN GENE-TRANSCRIPTION, NATURE 300: 192 (1982). · DOI
- OVERDUIN, M, 3-DIMENSIONAL SOLUTION STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF C-ABL, CELL 70: 697 (1992). · DOI
- PEARSE, R.N., INTERFERON-GAMMA-INDUCED TRANSCRIPTION OF THE HIGH-AFFINITY FC RECEPTOR FOR IGG REQUIRES ASSEMBLY OF A COMPLEX THAT INCLUDES THE 91-KDA SUBUNIT OF TRANSCRIPTION FACTOR ISGF3, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 4314 (1993).
- PELLEGRINI, S, USE OF A SELECTABLE MARKER REGULATED BY ALPHA INTERFERON TO OBTAIN MUTATIONS IN THE SIGNALING PATHWAY, MOLECULAR AND CELLULAR BIOLOGY 9: 4605 (1989).
- PINE, R, PURIFICATION AND CLONING OF INTERFERON-STIMULATED GENE FACTOR-2 (ISGF2) - ISGF2 (IRF-1) CAN BIND TO THE PROMOTERS OF BOTH BETA-INTERFERON-STIMULATED AND INTERFERON-STIMULATED GENES BUT IS NOT A PRIMARY TRANSCRIPTIONAL ACTIVATOR OF EITHER, MOLECULAR AND CELLULAR BIOLOGY 10: 2448 (1990).
- PORTER, ACG, INTERFERON RESPONSE ELEMENT OF THE HUMAN GENE-6-16, EMBO JOURNAL 7: 85 (1988). · DOI
- REICH, N, INTERFERON-INDUCED TRANSCRIPTION OF A GENE ENCODING A 15-KDA PROTEIN DEPENDS ON AN UPSTREAM ENHANCER ELEMENT, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 84: 6394 (1987).
- 10.1126/science.8378774 · DOI
- RUTHERFORD, M.N., INTERFERON-INDUCED BINDING OF NUCLEAR FACTORS TO PROMOTER ELEMENTS OF THE 2-5A SYNTHETASE GENE, EMBO JOURNAL 7: 751 (1988). · DOI
- 10.1126/science.8397445 · DOI
- SCHINDLER, C, PROTEINS OF TRANSCRIPTION FACTOR ISGF-3 - ONE GENE ENCODES THE 91-KDA AND 84-KDA ISGF-3 PROTEINS THAT ARE ACTIVATED BY INTERFERON-ALPHA, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 89: 7836 (1992).
- 10.1126/science.1496401 · DOI · Paper page
- SHIRAYOSHI, Y, INTERFERON-INDUCED TRANSCRIPTION OF A MAJOR HISTOCOMPATIBILITY CLASS-I GENE ACCOMPANIES BINDING OF INDUCIBLE NUCLEAR FACTORS TO THE INTERFERON CONSENSUS SEQUENCE, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 85: 5884 (1988).
- 10.1016/0092-8674(94)90357-3 · DOI · Paper page
- 10.1126/science.1281555 · DOI
- 10.1126/science.7690989 · DOI · Paper page
- SHUAL, K, POLYPEPTIDE SIGNALING TO THE NUCLEUS THROUGH TYROSINE PHOSPHORYLATION OF JAK AND STAT PROTEINS, NATURE 366: 580 (1993). · DOI
- SILVENNOINEN, O, INTERFERON-INDUCED NUCLEAR SIGNALING BY JAK PROTEIN-TYROSINE KINASES, NATURE 366: 583 (1993). · DOI
- SILVENNOINEN, O, STRUCTURE OF THE MURINE JAK2 PROTEIN-TYROSINE KINASE AND ITS ROLE IN INTERLEUKIN-3 SIGNAL-TRANSDUCTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 8429 (1993).
- 10.1126/science.8378775 · DOI
- SIMS, S. H., MOLECULAR AND CELLULAR BIOLOGY 13: 690 (1993).
- SOH, J, IDENTIFICATION AND SEQUENCE OF AN ACCESSORY FACTOR REQUIRED FOR ACTIVATION OF THE HUMAN INTERFERON-GAMMA RECEPTOR, CELL 76: 793 (1994). · DOI
- UZE, G, GENETIC TRANSFER OF A FUNCTIONAL HUMAN INTERFERON-ALPHA RECEPTOR INTO MOUSE CELLS - CLONING AND EXPRESSION OF ITS CDNA, CELL 60: 225 (1990). · DOI
- VEALS, S.A., SUBUNIT OF AN ALPHA-INTERFERON-RESPONSIVE TRANSCRIPTION FACTOR IS RELATED TO INTERFERON REGULATORY FACTOR AND MYB FAMILIES OF DNA-BINDING PROTEINS, MOLECULAR AND CELLULAR BIOLOGY 12: 3315 (1992).
- 10.1016/0092-8674(92)90105-L · DOI
- Wakao, H., EMBO J. 13: 2182 (1994). · DOI
- WATLING, D, COMPLEMENTATION BY THE PROTEIN-TYROSINE KINASE JAK2 OF A MUTANT-CELL LINE DEFECTIVE IN THE INTERFERON-GAMMA SIGNAL-TRANSDUCTION PATHWAY, NATURE 366: 166 (1993). · DOI
- WILKS, A.F., 2 NOVEL PROTEIN-TYROSINE KINASES, EACH WITH A 2ND PHOSPHOTRANSFERASE-RELATED CATALYTIC DOMAIN, DEFINE A NEW CLASS OF PROTEIN-KINASE, MOLECULAR AND CELLULAR BIOLOGY 11: 2057 (1991).
- WILKS, A.F., 2 PUTATIVE PROTEIN-TYROSINE KINASES IDENTIFIED BY APPLICATION OF THE POLYMERASE CHAIN-REACTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 86: 1603 (1989).
- WITTHUHN, B.A., JAK2 ASSOCIATES WITH THE ERYTHROPOIETIN RECEPTOR AND IS TYROSINE-PHOSPHORYLATED AND ACTIVATED FOLLOWING STIMULATION WITH ERYTHROPOIETIN, CELL 74: 227 (1993). · DOI
- Yamamato K. Molecular and Cellular Biology in press.
- Zhong, Z., Proceedings of the National Academy of Sciences of the United States of America 91: 4806 (1994).
Cited by
Sorted by citations
Items 701–800 of 1,078
Distinct immune response induced by peptidoglycan derived fromLactobacillus sp
Sun, J. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i40.6330 · Cited by 64
Hermanns, H. M., Radtke, S., Haan, C., Schmitz-Van de Leur, H., Tavernier, J., Heinrich, P. C., & Behrmann, I. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6651 · Cited by 71
Wang, L., Xian, Y., Loo, S. K. F., Ip, S., Yang, W., Chan, W. Y., Lin, Z., & Wu, J. C. Y. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105538 · Cited by 73
Ahluwalia, P. K., Pandey, R. K., Sehajpal, P. K., & Prajapati, V. K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00107 · Cited by 71
“These participate by expressing higher MHC-2, IL-12, and Nitric oxide synthase (NOS), necessary for killing of the pathogen (52).”
BackgroundWang, R., & Zhang, Y. (2014) · BioMed Research International · doi:10.1155/2014/315470 · Cited by 68
“PRRSV fails to induce porcine pDCs to produce IFN-𝛼, while pseudorabies virus (PrV), swine influenza virus (SIV), and TGEV stimulated the pDCs to synthesize IFN-𝛼 [26, 27].”
BackgroundValera, E., Ubhi, K. K., Mante, M., Rockenstein, E. M., & Masliah, E. (2013) · Glia · doi:10.1002/glia.22610 · Cited by 79
“…of the antidepressants used in this study normalized levels of cytokines that signal through the Jak-STAT pathway, such as G-CSF, IFN-c and IL-13 (Darnell et al., 1994; Tian et al., 1996; Welham et al., 1995), suggesting that NF-jB regulation might be mechanistically involved in the…”
BackgroundInfluentialLiao, J., Xu, T., Zheng, J., Lin, J., Cai, Q., Yu, D., & Peng, J. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1358 · Cited by 72
Camicia, R., Bachmann, S. B., Winkler, H. C., Beer, M., Tinguely, M., Haralambieva, E., & Hassa, P. O. (2013) · Journal of Cell Science · doi:10.1242/jcs.118174 · Cited by 66
“IFNGR–JAK2-mediated phosphorylation of STAT1 on Y701 is required for STAT1 dimerization and its nuclear translocation (Darnell et al., 1994; Mowen and David, 2000).”
BackgroundSouthworth, T. W., Metryka, A., Lea, S., Farrow, S. N., Plumb, J., & Singh, D. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01907.x · Cited by 74
“IFN-g activates the Janus kinase (JAK) – signal transducer and activator of transcription (STAT) intracellular signal pathway in macrophages, through phosphorylation of JAK2 leading to phosphorylation of STAT1 (Darnell et al., 1994).”
Hasmim, M., Noman, M. Z., Lauriol, J., Benlalam, H., Mallavialle, A., Rosselli, F., Mami‐Chouaib, F., Alcaïde‐Loridan, C., & Chouaı̈b, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101011 · Cited by 65
“5A indicates that silencing of hypoxia-induced NANOG resulted in an inhibition of STAT3 phosphorylation on Tyr(705), a crucial event for STAT3 dimerization and translocation to the nucleus (31).”
BackgroundSTAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment
Lavecchia, A., Giovanni, C. D., & Novellino, E. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795843218 · Cited by 68
“They are classically viewed as transducing cytokine- and growth factor-activated signals, migrating from the plasma membrane to the cell nucleus for the purpose of activating transcription [1-4].”
BackgroundSeo, Y., Blake, C., Alexander, S., & Hahm, B. (2010) · Journal of Virology · doi:10.1128/jvi.00510-10 · Cited by 72
“, phosphorylation of STAT1/2 molecules (1, 8, 41), was blocked by a specific inhibitor, the production of influenza virus NP increased preferentially in SPL cells (Fig.”
BackgroundMethodJohnson, K., & Knipe, D. (2009) · Virology · doi:10.1016/j.virol.2009.09.021 · Cited by 70
“Because Jak-1 activation is necessary for Stat-1 phosphorylation (Darnell, Kerr, and Stark, 1994; David et al., 1993; Johnson, Song, and Knipe, 2008; Platanias, Uddin, and Colamonici, 1994) these results suggested that the effect of HSV-1 was on a factor or signaling event upstream of Jak-1…”
Guo, C.-J., Zhang, Y.-F., Yang, L., Yang, X., Wu, Y., Liu, D., Chen, W., Weng, S., Yu, X., & He, J. (2009) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2009.06.001 · Cited by 73
Zhang, S. S.-M., Liu, M.-G., Kano, A., Zhang, C., Fu, X.-Y., & Barnstable, C. J. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.01.016 · Cited by 68
Selective inhibitors of JAK1 targeting an isoform-restricted allosteric cysteine
Kavanagh, M. E., Horning, B. D., Khattri, R., Roy, N., Lu, J. P., Whitby, L. R., Ye, E., Brannon, J. C., Parker, A., Chick, J. M., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01098-0 · Cited by 85
“understanding of JAK1 biology has relied on studies with conditional knockout mice lacking JAK1 in specific cell types 16,17 , JAK1-deficient human cell lines 18 and/or non-selective orthosteric inhibitors 19 .”
Wu, B., Liu, J., Li, Y., & Li, J. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4395 · Cited by 64
“p-STAT1 is required to promote M1 type macrophage activation in the presence of IFN-γ from innate lymphocytes (55).”
BackgroundTherapeutic Inducers of Apoptosis in Ovarian Cancer
Binju, M., Amaya-Padilla, M. A., Wan, G., Gunosewoyo, H., Rahmanto, Y. S., & Yu, Y. (2019) · Cancers · doi:10.3390/cancers11111786 · Cited by 78
“STAT3 is a transcription factor involved in the mediation of cytokines and growth factor signaling [132].”
BackgroundBolívar, S., Anfossi, R., Humeres, C. D., Vivar, R., Boza, P., Muñoz, C., Pardo-Jiménez, V., Olivares-Silva, F., & Díaz-Araya, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01368 · Cited by 72
“The cellular effects of IFN-β are mediated through the JAK/STAT signaling pathway and vary according to context and cell phenotype (Darnell et al., 1994; Ihle, 1995; Chen et al., 2004).”
BackgroundHe, C., Li, H., Viollet, B., Zou, M., & Xie, Z. (2015) · Diabetes · doi:10.2337/db15-0107 · Cited by 69
“Once activated, the phospho-STAT proteins translocated to the nucleus, bound to specific promoters, and induced the expression of target genes (30).”
BackgroundRosowski, E. E., Nguyen, Q., Camejo, A., Spooner, E., & Saeij, J. P. J. (2013) · Infection and Immunity · doi:10.1128/iai.01291-13 · Cited by 72
“cause constitutively associated Janus activated kinase 1 (JAK1) and JAK2 to be activated (15, 16).”
BackgroundSTAT3 inhibitors for cancer therapy
Fagard, R., Metelev, V., Souissi, I., & Baran‐Marszak, F. (2013) · JAK-STAT · doi:10.4161/jkst.22882 · Cited by 131
Investigation of NK cell function and their modulation in different malignancies
Konjević, G. M., Jurišić, V., Jović, V., Vuletić, A. M., Martinović, K. M., Radenković, S., & Spužić, I. (2012) · Immunologic Research · doi:10.1007/s12026-012-8285-7 · Cited by 77
“In this sense, it has been shown that immunoregulatory activities of IFN-a, used in adjuvant immunotherapy of high-risk melanoma, are mediated by a set of cellular genes [99] responsible for its biological effects, including STAT1 (signal transducers and activators of transcription 1) and STAT2 [100, 101].”
BackgroundBego, M. G., Mercier, J., & Cohen, É. A. (2012) · Journal of Virology · doi:10.1128/jvi.06971-11 · Cited by 70
“As controls, we used STAT1-expressing parental 2fTGH cells, U3A-R, a rescue cell line in which expression of STAT1 was stably reestablished through introduction of a construct encoding STAT1 under the control of a human cytomegalovirus immediate-early gene promoter, as well as U3A-701 cells, which express a phosphoryl…”
BackgroundMethodInfluentialPuhlmann, J., Puehler, F., Mumberg, D., Boukamp, P., & Beier, R. (2010) · Oncogene · doi:10.1038/onc.2009.507 · Cited by 63
“To further analyze the IFN pathway in these cells, we studied the activation and induction of STAT1 and 2 which are components of the JAK-STAT pathway and are activated as a consequence of IFN binding to its cell surface receptor (Darnell et al., 1994).”
IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma
Calvo, K. R., Dabir, B., Kovach, A. E., Devor, C. B., Bandle, R., Bond, A., Shih, J. H., & Jaffe, E. S. (2008) · Blood · doi:10.1182/blood-2008-02-138933 · Cited by 64
Osteoclast activation in inflammatory periodontal diseases
Wiebe, S. H., Hafezi, M., Sandhu, H., Sims, S. M., & Dixon, S. J. (1996) · Oral Diseases · doi:10.1111/j.1601-0825.1996.tb00218.x · Cited by 66
Cao, D., Tal, T. L., Graves, L. M., GILMOUR, I. J., Linak, W. P., REED, W. A., Bromberg, P. A., & Samet, J. M. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00204.2006 · Cited by 68
“STATs are a family of cytoplasmic transcription factors identified as being key mediators of physiological signaling by cytokines and growth factors (5, 6, 24).”
BackgroundCentral Role of ULK1 in Type I Interferon Signaling
Saleiro, D., Mehrotra, S., Kroczynska, B., Beauchamp, E. M., Lisowski, P., Majchrzak-Kita, B., Bhagat, T. D., Stein, B. L., McMahon, B., Altman, J. K., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.056 · Cited by 74
“No significant differences in IFNdependent Isg15, Isg54, and Irf9 mRNA expression were observed between control cells and cells in which ATG5 was knocked down (Figures 4A–4D).”
BackgroundInfluentialWei, J., Yuan, Y., Jin, C., Chen, H., Leng, L., He, F., & Wang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049567 · Cited by 65
“Both of the NF-kB and the JAK-STAT signaling pathways have a central role in the immune response, but the cross-talk between the two signaling pathways is not very clear [1] [11].”
BackgroundSTAT1 gene expression is enhanced by nuclear EGFR and HER2 via cooperation With STAT3
Han, W., Carpenter, R. L., Cao, X., & Lo, H. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21936 · Cited by 68
“To this end, we focused our efforts on signal transducer and activator of transcription 1 (STAT1), a transcription factor that responds to inflammatory signals and regulates genes involved in inflammatory response [37,38].”
Inhibiting aberrant Stat3 function with molecular therapeutics: a progress report
Haftchenary, S., Avadisian, M., & Gunning, P. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328341185b · Cited by 68
Nanda, S. K., & Baron, M. D. (2006) · Journal of Virology · doi:10.1128/jvi.02720-05 · Cited by 64
“The type I IFNs mediate their biological function by binding to the IFN- receptor on the target cells, resulting in the autophosphorylation and activation of the receptor-associated Janus kinases (JAKs), JAK1 and tyrosine kinase 2 (TYK2), and then the phosphorylation of the signaling molecules STAT1 and STAT2 (13, 29).”
BackgroundPhysical and Functional Interactions between STAP-2/BKS and STAT5
Sekine, Y., Yamamoto, T., Yumioka, T., Sugiyama, K., Tsuji, S., Oritani, K., Shimoda, K., Minoguchi, M., Yoshimura, A., & Matsuda, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411692200 · Cited by 59
MiR-122 modulates type I interferon expression through blocking suppressor of cytokine signaling 1
Li, A., Song, W., Qian, J., Li, Y., He, J., Zhang, Q., Li, W., Zhai, A., Kao, W., Hu, Y., et al. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.01.008 · Cited by 67
Gordon, R. A., Grigoriev, G., Lee, A., Kalliolias, G., & Ivashkiv, L. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34544 · Cited by 67
“The discovery of the JAK/STAT signaling pathway clarified that most of the “IFN -inducible genes” expressed in RA synovium are targets of STAT-1 (4).”
BackgroundMin, K., Choi, K.-H., & Kwon, T. K. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.02.029 · Cited by 62
“BV2 cells were transiently transfected with luciferase reporter plasmids containing 8 GAS elements and stimulated with 100 ng/ml LPS either in the presence or absence of withaferin A. LPS dramatically enhanced GAS luciferase activity by approximately 5.7-fold, but GAS luciferase activity was reduced by withaferin A in…”
BackgroundInfluentialS‐glutathionylation of IRF3 regulates IRF3–CBP interaction and activation of the IFNβ pathway
Prinarakis, E., Chantzoura, E., Thanos, D., & Spyrou, G. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.28 · Cited by 77
“…present on the cell surface and by doing so activate the JAK–STAT signalling pathway eliciting their effects through the transcriptional activation of target genes bearing specific DNA-binding recognition sites (ISREs) within their promoters (Darnell et al, 1994; Ihle, 1996; Stark et al, 1998).”
BackgroundMolecular mechanisms of immunotherapy resistance in triple-negative breast cancer
Zheng, Y., Li, S., Tang, H., Meng, X., & Zheng, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1153990 · Cited by 68
Hypoxia as a Modulator of Inflammation and Immune Response in Cancer
Castillo‐Rodríguez, R. A., Trejo‐Solís, C., Cabrera‐Cano, A., Gómez‐Manzo, S., & Dávila‐Borja, V. M. (2022) · Cancers · doi:10.3390/cancers14092291 · Cited by 70
Krishnamoorthy, M., Lenehan, J. G., & Vareki, S. M. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa216 · Cited by 75
“Both JAK1 and JAK2 are required for sensitivity to IFNc, which has antiproliferative effects (54,55).”
BackgroundCannabidiol as a Novel Therapeutic for Immune Modulation
Peyravian, N., Deo, S. K., Daunert, S., & Jimenez, J. J. (2020) · ImmunoTargets and Therapy · doi:10.2147/itt.s263690 · Cited by 79
Epstein–Barr Virus and Innate Immunity: Friends or Foes?
Jangra, S., Yuen, K., Botelho, M. G., & Jin, D. (2019) · Microorganisms · doi:10.3390/microorganisms7060183 · Cited by 74
“These kinases phosphorylate and activate STAT1 to form homodimers, also known as GAF [118].”
BackgroundMiR‐16 regulates mouse peritoneal macrophage polarization and affects T‐cell activation
Jia, X., Li, X., Shen, Y., Miao, J., Liu, H., Li, G., & Wang, Z. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12882 · Cited by 71
“found that the signal transducers and activators of transcription 1 (STAT1) homodimers induced by IFN-c engages the cis elements within the promoter region of target genes including iNOS and IL-12, promotes target gene expression and drives the M1 differentiation of macrophages [24].”
Backgroundvan Dijk, F., Olinga, P., Poelstra, K., & Beljaars, L. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00072 · Cited by 60
WHSC1 links transcription elongation to HIRA‐mediated histone H3.3 deposition
Sarai, N., Nimura, K., Tamura, T., Kanno, T., Patel, M. C., Heightman, T. D., Ura, K., & Ozato, K. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.176 · Cited by 73
“Whsc1 (cid:2) / (cid:2) and WT cells were stimulated with IFN b (hereafter IFN) at 100U/ml, an optimal concentration for ISG induction (Darnell et al , 1994).”
Pectasides, E., Egloff, A. M., Sasaki, C. T., Kountourakis, P., Burtness, B. A., Fountzilas, G., Dafni, U. G., Zaramboukas, T., Rampias, T. N., Rimm, D. L., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2658 · Cited by 65
“After activation, STAT proteins dimerize and translocate to the nucleus, where they bind to DNA-response elements and alter the transcription of genes controlling normal cell functions such as growth, apoptosis, and differentiation (2).”
BackgroundChang, K.-T., Tsai, C., Chiou, Y.-C., Chiu, C., Jeng, K.-S., & Huang, C. F. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00089.2005 · Cited by 68
“Subsequently, activated STATs form dimers and translocate to the nucleus where they bind specific promoter elements of target genes and regulate their transcription (12, 13, 20, 21).”
BackgroundNeutralizing antibodies and efficacy of interferon β-1a
Kappos, L., Clanet, M., Sandberg-wollheim, M., Radue, E., Hartung, H., Hohlfeld, R., Xu, J., Bennett, D., Sandrock, A., & Goelz, S. (2005) · Neurology · doi:10.1212/01.wnl.0000171747.59767.5c · Cited by 65
JAK/STAT signaling in insect innate immunity
Bang, I. S. (2019) · Entomological Research · doi:10.1111/1748-5967.12384 · Cited by 83
STAT3: A Potential Drug Target for Tumor and Inflammation
Hu, Y. S., Han, X., & Liu, X. H. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190620145052 · Cited by 81
Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors
Casimiro‐Garcia, A., Trujillo, J. I., Vajdos, F. F., Juba, B. M., Banker, M. E., AULABAUGH, A. E., Balbo, P., Bauman, J. N., Chrencik, J., Coe, J. W., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01308 · Cited by 85
Non‐canonical Stat3 signaling in cancer
Srivastava, J., & DiGiovanni, J. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22438 · Cited by 64
Rollins, D. A., Coppo, M., & Rogatsky, I. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1005 · Cited by 66
Tomasello, E., Pollet, É., Manh, T. V., Uzé, G., & Dalod, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00526 · Cited by 91
“IFNAR is composed of two distinct subunits, IFNAR1 and IFNAR2, which are constitutively associated with members of the JAK family, tyrosine kinase 2 (TYK2) and JAK1, respectively (186) .”
BackgroundA Critical Role for Interferon Regulatory Factor 9 in Cerebral Ischemic Stroke
Chen, H., Guo, S., Li, Z.-Z., Lu, Y., Jiang, D.-S., Zhang, R., Lei, H. C., Gao, L., Zhang, X., Zhang, Y., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1545-14.2014 · Cited by 66
Choi, J. H., Jin, S.-W., Han, E., Park, B., Kim, H. G., Khanal, T., Hwang, Y., Do, M. T., Lee, H.-S., Chung, Y., et al. (2014) · Phytomedicine · doi:10.1016/j.phymed.2014.04.011 · Cited by 65
Mechanism of the inhibition of the STAT3 signaling pathway by EGCG
Wang, Y., Ren, X., Deng, C., YANG, L., Yan, E., GUO, T., Li, Y., & Xu, M. X. (2013) · Oncology Reports · doi:10.3892/or.2013.2743 · Cited by 65
“In addition, human tumor xenograft studies in mice have repeatedly demonstrated that inhibition of STAT3 signaling results in decreased tumor growth and improved animal survival by inducing apoptosis in tumor cells, inhibiting angiogenesis (4), and enhancing antitumor immune-mediated cytotoxicity (1,5).”
Ubiquitin-Specific Proteases 25 Negatively Regulates Virus-Induced Type I Interferon Signaling
Zhong, H., Wang, D., Fang, L., Zhang, H., Luo, R., Shang, M., Ouyang, C., Ouyang, H., Chen, H., & Xiao, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080976 · Cited by 65
“The type I IFN signal is then transducted by the activation of Janus kinase (JAK) family protein kinases and the signal transducers and activators of transcription (STAT) family of proteins [2] , resulting in the generation of the transcriptional activator, IFN-stimulated gene factor 3 (ISGF3).”
BackgroundKing, C. A. (2013) · Journal of Virology · doi:10.1128/jvi.02976-12 · Cited by 71
“leading to the formation of dimers through reciprocal phosphotyrosine-SH2 domain interactions (31, 32).”
BackgroundYao, X.-Y., Li, G.-L., Xu, H., & Lu, C.-T. (2012) · Planta Medica · doi:10.1055/s-0032-1315303 · Cited by 65
The Role of MAPK in Drug-Induced Kidney Injury
Cassidy, H., Radford, R., Slyne, J., O’Connell, S., Slattery, C., Ryan, M. P., & McMorrow, T. (2012) · Journal of Signal Transduction · doi:10.1155/2012/463617 · Cited by 71
“Vancomycin is a cationic glycopeptide antibiotic used in the treatment of penicillin-resistant Gram-positive infections, methicillin-resistant Staphylococcus aureus infections, and Clostridium difficile infections, which has seen a resurgence in use due to the emergence of β-lactam-resistant Gram-positive organism-ass…”
BackgroundLin, H.-Y., Hou, S.-C., Chen, S.-C., Kao, M., Yu, C.-C., Funayama, S., Ho, C., & Way, T. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf204362n · Cited by 66
Interferon type I responses in primary and secondary infections
Alsharifi, M., Müllbacher, A., & Regner, M. (2008) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100159 · Cited by 62
Haan, S., Margue, C., Engrand, A., Rolvering, C., de Leur, H. S.-V., Heinrich, P. C., Behrmann, I., & Haan, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.998 · Cited by 63
“The STAT transcription factors are then tyrosine phosphorylated and translocate to the nucleus where they bind to specific DNA sequences in the promoter regions of their respective target genes (2, 3).”
BackgroundLü, Y., Liang, K., Li, X., & Fan, Z. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-63 · Cited by 63
“Even more divergent results were found in the levels of STAT3 phosphorylation after cetuximab and gefitinib treatment: levels of Tyr705-phosphorylated STAT3, which is regulated primarily via the JAK or Src kinase pathway [ 26 ], were markedly increased in A431 and H3255 cells; essentially unchanged or modestly increas…”
ResultZimmerer, J. M., Lesinski, G. B., Kondadasula, S. V., Karpa, V. I., Lehman, A., Ray‐Chaudhury, A., Becknell, B., & Carson, W. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4832 · Cited by 62
“The prototypical IFN- -signaling reaction results in the formation of IFN-stimulated gene factor 3, a DNA-binding complex that consists of STAT1 (or STAT1 ), STAT2, and IFN regulatory factor 9 (14).”
BackgroundHepatitis C Infection and Alcohol Use: A Dangerous Mix for the Liver and Antiviral Immunity
Szabó, G., Aloman, C., Polyak, S. J., Weinman, S. A., Wands, J. R., & Zakhari, S. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00083.x · Cited by 66
Muthian, G., Raikwar, H. P., Johnson, C., Rajasingh, J., Kalgutkar, A., Marnett, L., & Bright, J. (2006) · Journal of Clinical Immunology · doi:10.1007/s10875-006-8787-y · Cited by 65
Huang, Y., Qiu, J., Dong, S., Redell, M. S., Poli, V., Mancini, M. A., & Tweardy, D. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704548200 · Cited by 65
Abe, K., Hirai, M., Mizuno, K., Higashi, N., Sekimoto, T., Miki, T., Hirano, T., & Nakajima, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204461 · Cited by 65
Wang, I.-M., Blanco, J. C. G., Tsai, S. Y., Tsai, M.-J., & Ozato, K. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6313 · Cited by 64
Zhao, D., Cui, W., Liu, M., Li, J., Sun, Y., Shi, S., Lin, S., & Lin, Y. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c13839 · Cited by 82
Fu, M., Wang, B., Chen, X., He, Z., Wang, Y., Li, X., Cao, H., & Zheng, S. J. (2017) · Journal of Virology · doi:10.1128/jvi.01646-17 · Cited by 72
PLA2R1: Expression and function in cancer
Bernard, D., & Vindrieux, D. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.03.003 · Cited by 75
Elomaa, A.-P., NISKANEN, L. K., Herzig, K., Viinamäki, H. T., Hintikka, J. J., Koivumaa-Honkanen, H. T., Honkalampi, K. M., Valkonen‐Korhonen, M., Harvima, I. T., & Lehto, S. M. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-2 · Cited by 65
“IFN-a and -g have also been shown to activate JAK family kinases and consequently phosphorylate STATs [48], and further induce depressive symptoms [49].”
BackgroundTargeting Cancer Cell Ferroptosis to Reverse Immune Checkpoint Inhibitor Therapy Resistance
Deng, J., Zhou, M. L., Liao, T., Kuang, W., Xia, H., Yin, Z., Tan, Q., Li, Y., Song, S., Zhou, E., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.818453 · Cited by 63
Jia, H., Song, L., Cong, Q., Wang, J.-L., Xu, H., Chu, Y., Li, Q., Zhang, Y., Zou, X., Zhang, C.-M., et al. (2017) · Oncogene · doi:10.1038/onc.2016.418 · Cited by 63
Liu, Y., Sepich, D. S., & Solnica‐Krezel, L. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006564 · Cited by 58
“Signal transducer and activator of transcription 3 (STAT3) is an essential mediator of cytokine and growth factor signaling involved in animal development, homeostasis and disease [1, 2].”
BackgroundLin, G., Zhang, H., Sun, F., Lu, Z., Reed-Maldonado, A., Lee, Y.-C., Wang, G.-F., Banie, L., & Lue, T. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.02.03 · Cited by 63
“Transected peripheral nerves demonstrate elevated levels of JAK2, STAT1, and most importantly STAT3 (23).”
BackgroundInnate immune regulation by STAT ‐mediated transcriptional mechanisms
Li, H. S., & Watowich, S. S. (2014) · Immunological Reviews · doi:10.1111/imr.12198 · Cited by 72
“iNOS, IL-12, and CIITA) by direct binding to the gamma-activated sequence (GAS, a STAT consensus binding element) in their proximal promoters (117).”
BackgroundPharmacological Properties of Guggulsterones, the Major Active Components of Gum Guggul
Shah, R., Gulati, V., & Palombo, E. A. (2012) · Phytotherapy Research · doi:10.1002/ptr.4647 · Cited by 63
“26: 1594–1605 (2012) the transcription process (Darnell et al., 1994).”
Zak, M., Mendonca, R. V., Balázs, M., Barrett, K., Bergeron, P., Blair, W. S., Chang, C., Deshmukh, G., DeVoss, J., Dragovich, P. S., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300628c · Cited by 68
McCartney, E. M., Semendric, L., Helbig, K. J., Hinze, S. J., Jones, B., Weinman, S. A., & Beard, M. R. (2008) · The Journal of Infectious Diseases · doi:10.1086/593216 · Cited by 63
“The binding of IFN- to its cognate receptor results in the activation of the Jak/Stat signaling pathway [32], culminating in the expression of IFN-stimulated genes (ISGs) that act to limit HCV replication.”
BackgroundIFN‐γ‐induced IDO and WRS expression in microglia is differentially regulated by IL‐4
Yadav, M. C., Burudi, E. M. E., Alirezaei, M., Flynn, C. C., Watry, D. D., Lanigan, C. M. S., & Fox, H. S. (2007) · Glia · doi:10.1002/glia.20544 · Cited by 76
“Consequently, STAT-1 homodimers are formed and bind to IFN-g-inducible promoters (Darnell et al., 1994).”
BackgroundNeuroinflammation in retinitis pigmentosa: Therapies targeting the innate immune system
Zhao, L., Hou, C., & Yan, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1059947 · Cited by 65
The Role of Indoleamine 2, 3-Dioxygenase 1 in Regulating Tumor Microenvironment
Huang, X., Zhang, F., Wang, X., & Liu, K. (2022) · Cancers · doi:10.3390/cancers14112756 · Cited by 69
Tackling Chronic Inflammation with Withanolide Phytochemicals—A Withaferin A Perspective
Logie, E., & Berghe, W. V. (2020) · Antioxidants · doi:10.3390/antiox9111107 · Cited by 67
Pharmacological targets of metabolism in disease: Opportunities from macrophages
Castegna, A., Gissi, R., Menga, A., Montopoli, M., Favia, M., Viola, A., & Canton, M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107521 · Cited by 75
Lee, S.-B., Shin, J., Han, H.-S., Lee, H., Park, J. C., & Lee, K. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.02.022 · Cited by 67
Yang, L., & Zhang, Y. (2016) · Veterinary Microbiology · doi:10.1016/j.vetmic.2016.12.036 · Cited by 65
“PRRSV blocks the nuclear translocation of the IFNinduced ISGF3 complex via nsp1b (Chen et al., 2010; Patel et al., 2010).”
BackgroundInfluentialTargeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease
Szeląg, M., Piaszyk-Borychowska, A., Plens-Gałąska, M., Wesoły, J., & Bluyssen, H. A. R. (2016) · Oncotarget · doi:10.18632/oncotarget.9195 · Cited by 66
“Each IRF-DBD has the fold of a ‘helix-turn-helix’ and recognizes a similar DNA motifIFN regulatory element (IRE, NAANNGAAA) [25], that is present in the regulatory regions of IFNs and ISGs or binds to its tandem-repeat form called the IFN-stimulated response element (ISRE, A/GNGAAANNGAAACT) [26].”
BackgroundKim, H. S., Kim, D. C., Kim, H.-M., Kwon, H., Kwon, S. J., Kang, S., Kim, S. C., & Choi, G.-E. (2015) · Scientific Reports · doi:10.1038/srep13414 · Cited by 60
Mahajan, S., Hogan, J. K., Shlyakhter, D., Oh, L., Salituro, F. G., Farmer, L. J., & Hoock, T. C. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221176 · Cited by 64
“At the 10 mg/kg dose level in the CIA model, VX-509 produced significant inhibition of the immune-mediated pathology with exposure levels above the IC50 point for JAK3 while below the IC50 points for the JAK2/ JAK1/TYK2 assays.”
BackgroundMethodInfluentialXiao, H., Bid, H. K., Jou, D., Wu, X., Yu, W., Li, C., Houghton, P. J., & Lin, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616748 · Cited by 64
“Many drivers of STAT3 activation, including the anti-inflammatory IL-10, pro-inflammatory IL-6, and type I and II interferons (IFNs), ensure constitutive Stat3 activation, which may account for the fact that STAT3 can mediate both anti-inflammatory and pro-inflammatory responses (4, 25, 26).”
BackgroundmicroRNA control of interferons and interferon induced anti-viral activity
Sedger, L. M. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.07.009 · Cited by 66
Molecular pathways controlling inhibitory receptor expression
Grabenstatter, H. L., Russek, S. J., & Brooks‐Kayal, A. R. (2012) · Epilepsia · doi:10.1111/epi.12036 · Cited by 64
“Phosphorylated STAT proteins (pSTATs) dimerize and translocate to the nucleus where they bind specific STAT DNA regulatory elements in the promoters of target genes to alter their transcription (Darnell et al., 1994; Schindler & Darnell, 1995; Ihle, 1996; Levy & Darnell, 2002).”
MER41 Repeat Sequences Contain Inducible STAT1 Binding Sites
Schmid, C. D., & Bücher, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011425 · Cited by 67
“relatively few binding sequences defined a consensus sequence TCCNNNGAA of the IFN-c-activated site (GAS [13]).”
BackgroundMethodInfluentialClinical, Pathological and Molecular Determinants in Squamous Cell Carcinoma of the Oral Cavity
Al-Swiahb, J. N., Chen, C., Chuang, H., Fang, F., Tasi, H.-T., & Chien, C. (2010) · Future Oncology · doi:10.2217/fon.10.35 · Cited by 59
“STAT family members are latent cytoplasmic transcription factors activated by extracellular proteins, including growth factors, cytokines, hormones and peptides [82,83].”
BackgroundSarson, A., Parvizi, P., Lepp, D., Quinton, M., & Sharif, S. (2008) · Animal Genetics · doi:10.1111/j.1365-2052.2008.01710.x · Cited by 62
Metadata
- Authors
- Darnell, J. E., Kerr, L. M., & Stark, G. R.
- Affiliations
- Rockefeller University (US)
- Case Comprehensive Cancer Center (US)
- ORCID
- Stark, George R.
- Venue
- Science
- Published
- 1994-06-03
- Volume
- 264
- Issue
- 5164
- Pages
- 1415-1421
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2029275361
- Cited by
- 6,080
- References
- 85
- Citations by year
- 2026: 84 · 2025: 139 · 2024: 175 · 2023: 170 · 2022: 183 · 2021: 177 · 2020: 162 · 2019: 155 · 2018: 121 · 2017: 166 · 2016: 148 · 2015: 152 · 2014: 160 · 2013: 207 · 2012: 188
- FWCI
- 28.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- JAK/STAT signaling, interferon-alpha, interferon-gamma, signal transduction, STAT proteins, transcriptional activation, JAK kinases, interferon receptor, nuclear translocation, DNA binding
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cell Line, DNA-Binding Proteins, Genes, Genetic Complementation Test, Humans, Interferon-gamma, Molecular Sequence Data, Mutation, Protein-Tyrosine Kinases, Regulatory Sequences, Nucleic Acid, Transcription Factors, Signal Transduction, Transcriptional Activation, Interferon-alpha, Interferon-Stimulated Gene Factor 3, Interferon-Stimulated Gene Factor 3, gamma Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review